Literature DB >> 21315776

HuR and myogenesis: being in the right place at the right time.

Christopher von Roretz1, Pascal Beauchamp, Sergio Di Marco, Imed-Eddine Gallouzi.   

Abstract

The process of muscle cell differentiation into myotubes, termed myogenesis, depends on a complex coordination of myogenic factors, many of which are regulated post-transcriptionally. HuR, an mRNA-binding protein, is responsible for regulating the expression of several such myogenic factors by stabilizing their mRNAs. The critical role for HuR in myogenesis also involves the nucleocytoplasmic shuttling ability of this protein. Indeed, in order to perform its stabilizing functions, HuR must accumulate in the cytoplasm. This requires its dissociation from the import factor Transportin 2 (TRN2) which is actually caused by the cleavage of a portion of cytoplasmic HuR. In this review, we describe the roles of HuR during myogenesis, and the mechanisms regulating its cytoplasmic accumulation. This article is part of a Special Issue entitled: Regulation of Signaling and Cellular Fate through Modulation of Nuclear Protein Import. 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21315776     DOI: 10.1016/j.bbamcr.2011.01.036

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

1.  Effect of Inhibiting p38 on HuR Involving in β-AChR Post-transcriptional Mechanisms in Denervated Skeletal Muscle.

Authors:  Hong Wang; Xiao Zhao; Wang Yun; Lian-Hua Chen; Shi-Tong Li
Journal:  Cell Mol Neurobiol       Date:  2019-06-06       Impact factor: 5.046

Review 2.  RNA-binding proteins and gene regulation in myogenesis.

Authors:  Luciano H Apponi; Anita H Corbett; Grace K Pavlath
Journal:  Trends Pharmacol Sci       Date:  2011-10-06       Impact factor: 14.819

3.  Muscle development and regeneration controlled by AUF1-mediated stage-specific degradation of fate-determining checkpoint mRNAs.

Authors:  Dounia Abbadi; Ming Yang; Devon M Chenette; John J Andrews; Robert J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-21       Impact factor: 11.205

4.  HuR counteracts miR-330 to promote STAT3 translation during inflammation-induced muscle wasting.

Authors:  Souad Mubaid; Jennifer F Ma; Amr Omer; Kholoud Ashour; Xian J Lian; Brenda J Sanchez; Samantha Robinson; Anne Cammas; Virginie Dormoy-Raclet; Sergio Di Marco; Sridar V Chittur; Scott A Tenenbaum; Imed-Eddine Gallouzi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-12       Impact factor: 11.205

Review 5.  Drug delivery approaches for HuR-targeted therapy for lung cancer.

Authors:  Rajeswari Raguraman; Santny Shanmugarama; Meghna Mehta; Jo Elle Peterson; Yan D Zhao; Anupama Munshi; Rajagopal Ramesh
Journal:  Adv Drug Deliv Rev       Date:  2021-11-22       Impact factor: 15.470

6.  Multi-leveled suppression of p53 function by HuR IncRNPs.

Authors:  Jen-Hao Yang; Myriam Gorospe
Journal:  Noncoding RNA Investig       Date:  2018-01-17

Review 7.  Understanding and targeting the disease-related RNA binding protein human antigen R (HuR).

Authors:  Christopher W Schultz; Ranjan Preet; Teena Dhir; Dan A Dixon; Jonathan R Brody
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-01-23       Impact factor: 9.957

8.  Long noncoding RNAs, emerging players in muscle differentiation and disease.

Authors:  Maria Victoria Neguembor; Mathivanan Jothi; Davide Gabellini
Journal:  Skelet Muscle       Date:  2014-03-31       Impact factor: 4.912

9.  HuR and miR-1192 regulate myogenesis by modulating the translation of HMGB1 mRNA.

Authors:  Virginie Dormoy-Raclet; Anne Cammas; Barbara Celona; Xian Jin Lian; Kate van der Giessen; Marija Zivojnovic; Silvia Brunelli; Francesca Riuzzi; Guglielmo Sorci; Brian T Wilhelm; Sergio Di Marco; Rosario Donato; Marco E Bianchi; Imed-Eddine Gallouzi
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  A feedforward regulatory loop between HuR and the long noncoding RNA linc-MD1 controls early phases of myogenesis.

Authors:  Ivano Legnini; Mariangela Morlando; Arianna Mangiavacchi; Alessandro Fatica; Irene Bozzoni
Journal:  Mol Cell       Date:  2014-01-16       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.